Fractyl Health
GUTS | NASDAQ
$0.99
+$0.09 (+9.56%)
At close: Nov 16, 2026, 4:00 PM ET
$0.97
-$0.02 (-1.54%)
After-hours:
Nov 16, 2026, 7:30 PM ET
+9.56%
(1D)No price chart data available for 1D timeframe.
Rating
28
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #859/1021 (Top 84%)
Key Statistics
Market Data
Market Cap $13.16M
1D Range
0.92 1.08
52W Range
0.81 28.44
Valuation (TTM)
PE -0.17
PB -1.00
EV/EBITDA -0.56
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $5.00
Cash Flow
FCF Yield -573.3%
SBC Adj. FCF Yield -643.8%
SBC Impact -12.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -145.5% |
-25.8%
Dil EPS 3Y | 5Y 31.9% |
5.0%
FCF 3Y | 5Y -9.9% |
-16.9%
Returns
ROA -112.5%
ROE -1860.3%
ROIC -151.0%
Financial Health
Net Cash
$1.87M
Current Ratio 1.98
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient proced...
Sector Healthcare
Industry Biotechnology
Employees 100
IPO Date Feb 2, 2024
Website fractyl.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$5.00
Upside
+405.05%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove GUTS